Gamida Cell
Series D+Gamida Cell raised €7.6M in a Series D+ round in May 2012. The company is based in Jerusalem, Israel. Investors in the round: Amgen Ventures, Auriga Partners. Data as of Nov 2026.
Amount raised
€7.6M
€7,567,731
Native amount
10,000,000 USD
Stage
Series D+
series e
Investors
2
Provenance & confidence
UnverifiedAmount
10,000,000 USD
ECB-at-date → €7.6M · rate 1.3214 on 2012-04-30
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
May 2012
Round type
series e
Amount (EUR)
€7.6M